TBL1XR1 and acute lymphoblastic leukemia: 15% of acute lymphoblastic leukemia (ALL) patients with the ETV6-RUNX1 fusion had TBL1XR1 deletions, which made SMRT/N-CoR less effective at governing gene expression appropriately (20).